Last week, the US Senate unanimously approved SC Republican Jim DeMint's amendment to the FDA reauthorization bill stating the agency must have risk assessment and solution strategies in place with the manufacturer of RU-486 within seven months after the bill takes effect.
Pro-aborts in the Democrat-controlled body must have finally conducted a self risk assessment and determined they were close to being labeled as anti-women's health and safety if they didn't do something about RU-486.
Only last month, the Health, Education, Labor and Pensions Committee rejected Sen. Tom Coburn's amendment mostly on party lines, 12-8, to suspend sales of RU-486 altogether. This is very serious.
The abortion industry, mindless of women's health if it interferes with abortion, bulldozed FDA approval of RU-486 during the waning Clinton days in 2000 via an acceleration process supposed to be reserved for "life-threatening illnesses."
RU-486 is interesting in that it doesn't protect against life-threatening illnesses, it causes lives to end, and apparently not just preborn children. Perhaps the FDA became confused.
Since its rush approval, RU-486 has been linked to the deaths of at least seven American women, most due to toxic shock syndrome from the deadly bactium Clostridium sordellii, which may be an emerging risk of using RU-486.
The much publicized death of 18-year-old Holly Patterson in 2003 from RU-486 should have moved the FDA to pull RU-486 off the market, but it did not. It merely added a list of risks to RU-486's label.
The FDA has now received reports of 1,050 additional women who experienced adverse events from the RU-486 regimen including 9 life-threatening incidents, 232 hospitalizations, 116 blood transfusions, and 88 cases of infection, according to DeMint.
